Industry: Internet Region: Europe Deal Price: $1 million Deal method: Equity investment
Project Overview
A startup from the south of France, operating globally, with partnership agreements with 8 major pharmaceutical companies and projects in 7 countries/regions.
Project Strengths
Focused on the pharmaceutical IT industry, the company offers a digital platform powered by artificial intelligence, machine learning and natural language processing, designed to provide pharmaceutical companies with data and information to drive their pharmaceutical marketing strategies. The digital platform is focused on cancer and chronic disease research, collecting longitudinal real-world data from patients. virtual Companion answers questions related to patients' diseases and provides them with the information, advice and personalized support they are looking for at every stage of the healthcare pathway. It also identifies clinical trials based on patient profiles, shares the experiences of other patients with similar profiles, and allows patients to track changes in their condition through treatment logs.
Intent to partner
The company seeks collaborations for outsourcing agreements from organizations that are:
1. Pharmaceutical companies interested in increasing patient engagement and improving the quality of their medicines (positions include: product managers, marketing executives, business unit heads, innovation executives). In such cases, the company will provide services to pharmaceutical companies.
2. Pharmaceutical companies interested in generating real data directly to patients (positions include: head of R&D, head of clinical trials, data specialists).